Who Paid My Doc
John Pesando
Hematology & Oncology Seattle, WA Medical Doctor
NPI 1477150969 CMS profile 8797831
1066 East Blaine Street, Seattle, WA 98102
General payments
$15,676,499
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, John Pesando of Seattle, WA is reported in the CMS Open Payments database as having received $15,676,499 across 101 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 99th percentile of Hematology & Oncology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
6 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $2,883,079 | 17 | |
| 2024 | General | $2,366,194 | 18 | |
| 2023 | General | $2,750,844 | 15 | |
| 2022 | General | $2,721,018 | 18 | |
| 2021 | General | $2,542,320 | 17 | |
| 2020 | General | $2,413,044 | 16 |
Beside peers
- John Pesando
- Hematology & Oncology median
- Middle half of Hematology & Oncology
- National median
In program year 2025, general payments to John Pesando were reported at $2,883,079. Among 8,769 Hematology & Oncology profiles paid that year, the median was $683 and the middle half received between $143 and $3,154.
Show as a table
| Year | John Pesando | Hematology & Oncology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $529 | $121–$2,516 | $163 |
| 2020 | $2,413,044 | $339 | $82–$2,213 | $114 |
| 2021 | $2,542,320 | $263 | $49–$1,965 | $132 |
| 2022 | $2,721,018 | $416 | $103–$2,395 | $149 |
| 2023 | $2,750,844 | $542 | $125–$2,646 | $160 |
| 2024 | $2,366,194 | $692 | $141–$3,008 | $164 |
| 2025 | $2,883,079 | $683 | $143–$3,154 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
101 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Hematology & Oncology in Washington
Related records
Hematology & Oncology in Washington
Practitioners in the same specialty and state, ranked by reported value.
All Hematology & Oncology
Everyone recorded under this specialty, nationwide.
Doctors in Washington
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.